Armenia vs Mauritania: HIV/AIDS deaths averted by antiretroviral therapy
Armenia
267.92 deaths
in 2024
Mauritania
277.42 deaths
in 2024
Armenia rank
105th
Mauritania rank
103rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Armenia
- Mauritania
How they compare
Mauritania currently reports 277.42 deaths against 267.92 deaths in Armenia, a difference of 9.5 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Mauritania ahead.
Armenia ranks 105th and Mauritania ranks 103rd of 157 countries.
Mauritania has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Armenia | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 7.12 deaths | 89.77 deaths | 82.65 deaths | Mauritania |
| 2010s | 94.52 deaths | 261.27 deaths | 166.76 deaths | Mauritania |
| 2020s | 226.81 deaths | 276.93 deaths | 50.12 deaths | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Armenia or Mauritania?
- Mauritania, at 277.42 deaths against 267.92 deaths in Armenia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Armenia and Mauritania?
- 9.5 deaths, with Mauritania ahead.
- How many years of comparable data are there for Armenia and Mauritania?
- 35 years are reported by both, from 1990 to 2024.
- How do Armenia and Mauritania rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Armenia ranks 105th and Mauritania ranks 103rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.